PL2087104T3 - Podłoże suplementowane do produkcji wirusa - Google Patents
Podłoże suplementowane do produkcji wirusaInfo
- Publication number
- PL2087104T3 PL2087104T3 PL07821171T PL07821171T PL2087104T3 PL 2087104 T3 PL2087104 T3 PL 2087104T3 PL 07821171 T PL07821171 T PL 07821171T PL 07821171 T PL07821171 T PL 07821171T PL 2087104 T3 PL2087104 T3 PL 2087104T3
- Authority
- PL
- Poland
- Prior art keywords
- virus production
- medium supplement
- supplement
- medium
- virus
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 239000012913 medium supplement Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06450142A EP1911836A1 (en) | 2006-10-12 | 2006-10-12 | Medium supplement for virus production |
| EP07821171A EP2087104B1 (en) | 2006-10-12 | 2007-10-11 | Medium supplement for virus production |
| PCT/EP2007/060804 WO2008043805A1 (en) | 2006-10-12 | 2007-10-11 | Medium supplement for virus production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2087104T3 true PL2087104T3 (pl) | 2014-01-31 |
Family
ID=37834203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07821171T PL2087104T3 (pl) | 2006-10-12 | 2007-10-11 | Podłoże suplementowane do produkcji wirusa |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8288145B2 (pl) |
| EP (2) | EP1911836A1 (pl) |
| JP (1) | JP5298377B2 (pl) |
| KR (1) | KR101485441B1 (pl) |
| CN (2) | CN103232976A (pl) |
| AU (1) | AU2007306324C1 (pl) |
| CA (1) | CA2665603C (pl) |
| EA (1) | EA018438B1 (pl) |
| ES (1) | ES2403098T3 (pl) |
| PL (1) | PL2087104T3 (pl) |
| WO (1) | WO2008043805A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8883479B2 (en) | 2008-11-25 | 2014-11-11 | Baxter Healthcare Sa | Method for production of pH stable enveloped viruses |
| EP2512508B1 (en) * | 2009-07-22 | 2015-09-02 | Baxter Healthcare SA | Novel influenza virus |
| AR080972A1 (es) | 2010-04-28 | 2012-05-23 | Abbott Biologicals Bv | Produccion de componentes virales |
| CN103223162B (zh) * | 2013-04-03 | 2014-07-30 | 华南农业大学 | 一株h3n2犬流感病毒株cgd1的应用 |
| WO2015032043A1 (zh) * | 2013-09-04 | 2015-03-12 | 华为技术有限公司 | 传输数据的方法、装置和系统 |
| EP3980060A4 (en) | 2019-06-07 | 2023-04-12 | Flugen, Inc. | FLU VIRUS BACKBONE |
| WO2022020469A1 (en) | 2020-07-21 | 2022-01-27 | Flugen, Inc. | Influenza virus backbone |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783411A (en) * | 1984-10-22 | 1988-11-08 | Janis Gabliks | Influenza-A virus vaccine from fish cell cultures |
| EP1820512B1 (en) * | 1994-05-10 | 2013-07-03 | Boehringer Ingelheim Vetmedica, Inc. | Improved modified live brsv vaccine |
| US5824536A (en) | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
| DE69937999T2 (de) | 1998-06-12 | 2009-01-29 | Avir Green Hills Biotechnology Research Development Trade Ag | Interferon induzierende genetisch veränderte attenuierte viren |
| SK288544B6 (sk) | 1998-06-12 | 2018-03-05 | Mount Sinai School Of Medicine | Geneticky skonštruovaný oslabený chimérny vírus chrípky, vakcinačný prostriedok a farmaceutický prostriedok s jeho obsahom a ich použitie |
| US20020049167A1 (en) * | 2000-03-22 | 2002-04-25 | David Abraham | Azithromycin as a therapeutic agent for infections with leishmania parasites |
| TWI295688B (en) * | 2000-06-07 | 2008-04-11 | A method for inhibition of enterovirus and/or influenza virus reproduction by allophycocyanin in vitro | |
| ATE434035T1 (de) * | 2000-09-25 | 2009-07-15 | Polymun Scient Immunbio Forsch | Lebender influenza impfstoff und verfahren zu seiner herstellung |
| US20030018074A1 (en) * | 2001-07-06 | 2003-01-23 | Robert Kleiman | Antiviral composition and treatment method |
| JP2003327536A (ja) * | 2002-03-07 | 2003-11-19 | Kitasato Inst:The | ヒト免疫不全症候群ウイルスの感染、増殖抑制剤 |
| US7588774B2 (en) * | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
| WO2004110473A1 (en) * | 2003-05-27 | 2004-12-23 | Theravance, Inc. | Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| DE102007019191B4 (de) | 2006-07-10 | 2016-09-22 | Gea Westfaliasurge Gmbh | Zitzengummi mit stoßabsorbierenden Eigenschaften |
-
2006
- 2006-10-12 EP EP06450142A patent/EP1911836A1/en not_active Withdrawn
-
2007
- 2007-10-11 WO PCT/EP2007/060804 patent/WO2008043805A1/en not_active Ceased
- 2007-10-11 EA EA200900526A patent/EA018438B1/ru not_active IP Right Cessation
- 2007-10-11 AU AU2007306324A patent/AU2007306324C1/en not_active Ceased
- 2007-10-11 US US12/444,248 patent/US8288145B2/en active Active
- 2007-10-11 JP JP2009531844A patent/JP5298377B2/ja active Active
- 2007-10-11 KR KR1020097007994A patent/KR101485441B1/ko active Active
- 2007-10-11 CN CN201310051392XA patent/CN103232976A/zh active Pending
- 2007-10-11 CN CN2007800460588A patent/CN101568639B/zh active Active
- 2007-10-11 PL PL07821171T patent/PL2087104T3/pl unknown
- 2007-10-11 CA CA2665603A patent/CA2665603C/en active Active
- 2007-10-11 EP EP07821171A patent/EP2087104B1/en active Active
- 2007-10-11 ES ES07821171T patent/ES2403098T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011502466A (ja) | 2011-01-27 |
| KR20090064584A (ko) | 2009-06-19 |
| EP2087104A1 (en) | 2009-08-12 |
| US8288145B2 (en) | 2012-10-16 |
| EP2087104B1 (en) | 2013-01-23 |
| AU2007306324B2 (en) | 2013-07-18 |
| KR101485441B1 (ko) | 2015-01-26 |
| JP5298377B2 (ja) | 2013-09-25 |
| CN101568639B (zh) | 2013-03-27 |
| EA200900526A1 (ru) | 2009-12-30 |
| CA2665603A1 (en) | 2008-04-17 |
| WO2008043805A1 (en) | 2008-04-17 |
| CN101568639A (zh) | 2009-10-28 |
| CN103232976A (zh) | 2013-08-07 |
| CA2665603C (en) | 2016-10-04 |
| EP1911836A1 (en) | 2008-04-16 |
| AU2007306324A1 (en) | 2008-04-17 |
| ES2403098T3 (es) | 2013-05-14 |
| AU2007306324C1 (en) | 2013-11-07 |
| EA018438B1 (ru) | 2013-08-30 |
| US20100003221A1 (en) | 2010-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2222161A4 (en) | QUINOXALINYL DERIVATIVES | |
| IL194367A0 (en) | Dihydropyrazolopyrimidinone derivatives | |
| ZA200901336B (en) | Pyridizinone derivatives | |
| IL193641A0 (en) | Spiroindolinone derivatives | |
| IL195013A0 (en) | Pyridopyrimidinone derivatives | |
| IL198319A0 (en) | Spiroindolinone derivatives | |
| IL195422A0 (en) | 2-pyrazinecarboxamide derivatives | |
| IL192401A0 (en) | Indol-3-yl-carbonyl-spiro-piperidine derivatives | |
| ZA200809800B (en) | 2-Thioxanthine derivatives acting as Mpo-inhibitors | |
| IL198059A0 (en) | 2-aminocarbonyl-pyridine derivatives | |
| IL196364A0 (en) | Aminoindazolylurea derivatives | |
| IL193211A0 (en) | Indazole-heteroaryl derivatives | |
| ZA200904028B (en) | 5-Hydroxymethyl-oxazolidin-2-one derivatives | |
| IL197152A0 (en) | 5-phenyl-nicotinamide derivatives | |
| ZA200807460B (en) | Spiroindolinone derivatives | |
| IL197239A0 (en) | Phenyloxyaniline derivatives | |
| GB0610009D0 (en) | Culture medium | |
| GB0606679D0 (en) | Aerofoil | |
| GB0615237D0 (en) | Cyclists aid | |
| GB2439330B (en) | Aerofoil | |
| ZA200808462B (en) | Sulfonyl-3-heterocyclindazole derivatives as 5-hydroxytrpt-amine-6 ligands | |
| GB0614154D0 (en) | Novel Pyriazine Derivatives | |
| GB0600637D0 (en) | Supplement | |
| HU0600278D0 (en) | New process | |
| GB0624214D0 (en) | Benzotriazepinone derivatives |